Anita Graham
Human Resources Officer en LABORATORY CORPORATION OF AMERICA HOLDINGS .
Fortuna: 969 571 $ al 31/03/2024
Perfil
Anita Z.
Graham is currently the Chief Human Resources Officer & Executive VP at Laboratory Corp.
of America Holdings.
Previously, she held positions as Vice President-Human Resources at Cytyc Corp., Chief Administrative Officer at Shire Plc from 2004 to 2008, Chief Human Resources Officer & Vice President at VF Corp.
from 2014 to 2023, Chief Administrative Officer at Shire Acquisition, Inc. from 2004 to 2008, Chief Administrative Officer & Executive VP at Shire Plc, Chief Human Resources & Administrative Officer at The ADT Security Corp.
from 2012 to 2013, Principal-Human Resources at Zurich Scudder Investments, Inc., and Head-Human Resources at EMD Serono, Inc. Ms. Graham completed her undergraduate degree at Cornell University and holds an MBA from The Leonard N Stern School of Business.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
V.F. CORPORATION
0.02% | 18/10/2022 | 59 047 ( 0.02% ) | 905 781 $ | 31/03/2024 |
20/03/2024 | 292 ( 0.00% ) | 63 790 $ | 31/03/2024 |
Cargos activos de Anita Graham
Empresas | Cargo | Inicio |
---|---|---|
LABORATORY CORPORATION OF AMERICA HOLDINGS | Human Resources Officer | - |
Antiguos cargos conocidos de Anita Graham.
Empresas | Cargo | Fin |
---|---|---|
VF CORPORATION | Public Communications Contact | 01/01/2023 |
ADT CORP | Chief Administrative Officer | 31/12/2013 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Chief Administrative Officer | 23/05/2008 |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is the researching, development and marketing of prescription medicines. The Group operations focuses on three therapeutic areas - central nervous system disorders, gastrointestinal and renal diseases. The Group's marketed products for such disorders include ADDERALL and ADDERALL XR, for attention deficit hyperactivity disorder, REMINYL for Alzheimer's, co-marketed with Johnson and Johnson and CARBATROL. for epilepsy. The Group is also developing a range of treatments for ADHD which may treat children, adolescents and adults extending the use of its current brand as well as researching non-scheduled compounds. The Group operates in the United Kingdom, the United States of America, France, Germany, Italy, Spain, Ireland, Canada, the Netherlands and the Cayman Islands. | Chief Administrative Officer | 12/03/2008 |
SHIRE | Chief Administrative Officer | - |
Formación de Anita Graham.
Cornell University | Undergraduate Degree |
The Leonard N Stern School of Business | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
VF CORPORATION | Consumer Non-Durables |
Empresas privadas | 7 |
---|---|
Cytyc Corp.
Cytyc Corp. Medical SpecialtiesHealth Technology Cytyc Corp. manufactures and markets medical diagnostic applications. The company is headquartered in Marlborough, MA. | Health Technology |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Shire is a global specialty pharmaceutical company marketing products to defined customer groups (specialist doctors). Sales and marketing is a core Shire competence. Shire combines investment in product development with careful attention to risk management. Shire currently focuses on three therapeutic areas - central nervous system disorders (CNS), gastrointestinal (GI) and renal diseases. Shire has particular expertise in ADHD as a result of its development and marketing of the leading brand in the US market, ADDERALL and the new once a day version, ADDERALL XR. The group has a sales and marketing infrastructure with a broad portfolio of products targeting the US, Canada, UK, Republic of Ireland, France, Germany, Italy and Spain. Shire covers other significant pharmaceutical markets indirectly through distributors. They have already appointed such distributors including, Australia, Denmark, Finland, Hong Kong, Israel, Malaysia, Norway, Philippines, Singapore, South Africa, South Korea and Thailand. It is founded in 1986 | Commercial Services |
Shire Acquisition, Inc.
Shire Acquisition, Inc. Pharmaceuticals: MajorHealth Technology The Group's principal activity is the researching, development and marketing of prescription medicines. The Group operations focuses on three therapeutic areas - central nervous system disorders, gastrointestinal and renal diseases. The Group's marketed products for such disorders include ADDERALL and ADDERALL XR, for attention deficit hyperactivity disorder, REMINYL for Alzheimer's, co-marketed with Johnson and Johnson and CARBATROL. for epilepsy. The Group is also developing a range of treatments for ADHD which may treat children, adolescents and adults extending the use of its current brand as well as researching non-scheduled compounds. The Group operates in the United Kingdom, the United States of America, France, Germany, Italy, Spain, Ireland, Canada, the Netherlands and the Cayman Islands. | Health Technology |
Shire Plc
Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
The ADT Security Corp.
The ADT Security Corp. Miscellaneous Commercial ServicesCommercial Services The ADT Security Corp. engages in the provision of electronic security, interactive home and business automation, and related monitoring services. The company was founded on January 18, 2012 and is headquartered in Boca Raton, FL. | Commercial Services |
Zurich Scudder Investments, Inc. | Finance |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Anita Graham